missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ Human EHD2 (aa 388-476) Control Fragment Recombinant Protein
Click to view available options
Quantity:
100 μL
Unit Size:
100µL
Description
Highest antigen sequence indentity to the following orthologs: Mouse (92%), Rat (92%). This recombinant protein control fragment may be used for blocking experiments with the corresponding antibody, PA5-61497 (PA5-61497. In IHC/ICC and WB experiments, we recommend a 100x molar excess of the protein fragment control based on the concentration and the molecular weight. Pre-incubate the antibody-protein control fragment mixture for 30 min at room temperature.
This gene encodes a member of the EH domain-containing protein family. These proteins are characterized by a C-terminal EF-hand domain, a nucleotide-binding consensus site at the N terminus and a bipartite nuclear localization signal. The encoded protein interacts with the actin cytoskeleton through an N-terminal domain and also binds to an EH domain-binding protein through the C-terminal EH domain. This interaction appears to connect clathrin-dependent endocytosis to actin, suggesting that this gene product participates in the endocytic pathway.
Specifications
Specifications
| Accession Number | Q9NZN4 |
| Concentration | ≥5.0 mg/mL |
| For Use With (Application) | Blocking Assay, Control |
| Formulation | 1 M urea, PBS with no preservative; pH 7.4 |
| Gene ID (Entrez) | 30846 |
| Name | Human EHD2 (aa 388-476) Control Fragment |
| Quantity | 100 μL |
| Regulatory Status | RUO |
| Gene Alias | BC027084; C130052H20Rik; EH domain containing 2; EH domain-containing protein 2; Ehd2; EH-domain containing 2; FLJ96617; MGEPS; PAST homolog 2; PAST2; putative eps protein |
| Common Name | EHD2 |
| Show More |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction